tiprankstipranks
Immix Biopharma, Inc. (IMMX)
NASDAQ:IMMX
US Market

Immix Biopharma, Inc. (IMMX) Income Statement

Compare
131 Followers

Immix Biopharma, Inc. Income Statement

Last quarter (Q3 2024), Immix Biopharma, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Immix Biopharma, Inc.'s net income was $-7.15M. See Immix Biopharma, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ -89.52M$ 0.00$ 0.00$ 0.00
Gross Profit
$ -5.47K$ -89.52M$ -2.47K$ -2.32K$ -1.08K
Operating Expenses
$ 16.14M$ 8.22M$ 1.35M$ 453.85K$ 842.50K
Depreciation and Amortization
$ 5.47K$ 2.13K$ 2.47K$ 2.32K$ 1.08K
EBITDA
$ -16.14M$ -8.22M$ -1.35M$ -451.53K$ -841.20K
Operating Income
$ -16.14M$ -8.22M$ -1.35M$ -453.85K$ -842.50K
Other Income/Expenses
$ 572.01K$ -497.00$ -23.03M$ -676.46K$ -109.76K
Pretax Income
$ -15.57M$ -8.22M$ -24.38M$ -1.13M$ -952.26K
Net Income
$ -15.43M$ -8.23M$ -24.38M$ -1.15M$ -972.81K
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.89$ -0.62$ -1.84$ -0.15$ -0.29
Diluted EPS
$ -0.89$ -0.62$ -1.84$ -0.15$ -0.29
Weighted Average Shares Outstanding
17.34M 13.23M 13.23M 7.77M 3.38M
Weighted Average Shares Outstanding (Diluted)
17.34M 13.23M 13.23M 7.77M 3.38M
Currency in USD

Immix Biopharma, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis